Pfizer revenue drops 8% to $10.87bn

Pfizer revenue drops 8% to $10.87bn

Pharmaceutical giant Pfizer — which employs 2,000 people in Ireland — reported a 2% decline in first-quarter earnings to $2.7 billion, in line with the company’s projections.

First quarter earnings were hurt by declining sales, an increase in the effective tax rate and costs linked to Pfizer’s acquisition of rival drug company Wyeth. Sales of its Lipitor cholesterol fighter and its Chantix anti-smoking drug were sharply lower.

Excluding once-off items, Pfizer earned 54 cents per share, ahead of most analysts’ expectations of 49 cents.

The company’s worldwide revenue fell 8% to $10.87bn (€8.2bn). Revenue would have fallen by only 3% if not for the strengthening dollar, which lowers the value of overseas sales when converted back to US dollars.

Article courtesy of the Evening Echo newspaper.

More in this Section

Amazon deal with Deliveroo investigated by UK competition watchdogAmazon deal with Deliveroo investigated by UK competition watchdog

Falling fuel costs keep UK inflation at lowest since 2016Falling fuel costs keep UK inflation at lowest since 2016

Significant risks in extremely complex UK border Brexit preparations – watchdogSignificant risks in extremely complex UK border Brexit preparations – watchdog

Global fund managers ignore stock market rally to keep cashGlobal fund managers ignore stock market rally to keep cash


Lifestyle

I am dating a lovely guy. However, he seems really awkward about being naked in front of me.Sex File: Boyfriend keeps his T-shirt on during sex

To instantly power up your look, veer towards the hard shoulder.Bold shoulder: How to instantly power up your look

Plums are a wonderful autumn fruit, useful for all sorts of recipes both sweet and savoury. In Ireland we are blessed with wonderfully sweet plums.Currabinny Cooks: Juicy plums work for both sweet and savoury dishes

The rise of home skincare devices doesn't mean that salons and clinics no longer serve a purpose.The Skin Nerd: Don’t try this at home — new treatments in the salon

More From The Irish Examiner